article · Annals of Oncology

2321P Hospital time impact of subcutaneous vs intravenous anti-HER2 therapies in Egypt: A time-motion study

Emad Shash
M.A. Osman
W. El Sagheer
Hesham M. Amin
Noha O.A. Mohammed
R. M. Sayed
Ghada Moussa
Adam Khalifa
Mohammed Aladdin
Lamia T. Abou El-Kassem
A.H. Abdelaziz
O.M.R. Khorshid
Islam Fawzy Anan

2025Ain Shams University Hospital

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Safe Handling of Antineoplastic Drugs
HER2/EGFR in Cancer Research
Pharmaceutical Quality and Counterfeiting

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.annonc.2025.08.2937

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.